BackConduit Pharmaceuticals- Warrants (22/09/2028) Overview
Conduit Pharmaceuticals Inc - Warrants (22/09/2028)

Conduit Pharmaceuticals- Warrants (22/09/2028) Debt to Equity

Conduit Pharmaceuticals- Warrants (22/09/2028) (CDTTW) has a debt-to-equity ratio of 0.95, above the sector sector average of 0.2.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

0.95

Debt to Equity

0.95

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) (CDTTW) FAQ

As of the most recent data, CDTTW shows a debt-to-equity ratio of 0.95. That is above the sector sector average of 0.2. Scroll down for historical charts and peer comparison views.

The its sector sector average debt-to-equity ratio is about 0.2. Conduit Pharmaceuticals- Warrants (22/09/2028) is at 0.95, which is higher that average. That is roughly 372.5% above the sector mean. Use the comparison chart on this page to see how CDTTW stacks up against individual peers as well.

Investors watch CDTTW's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Conduit Pharmaceuticals- Warrants (22/09/2028)'s latest reading is 0.95. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Conduit Pharmaceuticals- Warrants (22/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 0.95) with ownership activity and broader fundamentals.